Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Norgine |
---|---|
Information provided by: | Norgine |
ClinicalTrials.gov Identifier: | NCT00868985 |
The study is to evaluate the influence of three different doses of PEG 3350 with or without electrolytes on the electrolyte balance in patient volunteers with confirmed chronic constipation.
Condition | Intervention | Phase |
---|---|---|
Chronic Constipation |
Drug: PEG 3350 plus electrolytes Drug: PEG 3350 without electrolytes |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Parallel Assignment |
Official Title: | Effects of Oral PEG 3350 on the Electrolyte Balance in Patient Volunteers With Chronic Constipation:Pharmacokinetic Evaluation |
Enrollment: | 114 |
Study Start Date: | January 2008 |
Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
PEG 3350 plus electrolytes: Experimental
Patients were dosed with PEG 3350 with electrolytes
|
Drug: PEG 3350 plus electrolytes
Each patient was treated with PEG 3350 with electrolytes for 10 days at a dose of either one, two or three sachets per day.
|
PEG 3350 without electrolytes: Experimental
Patients were dosed with PEG 3350 without electrolytes
|
Drug: PEG 3350 without electrolytes
Each patient was treated with PEG 3350 for 10 days at a dose of either one, two or three sachets per day.
|
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Patients with diagnosis or evidence of the following diseases: Hypothyroidism, diabetes mellitus, porphyria, pituitary gland insufficiency, pheochromocytoma, glucagonoma, neurological diseases (eg Hirschprung disease, neurofibromatosis, Chagas disease, stroke, autonomous neuropathy, intestinal pseudoobstruction, Multiple sclerosis, medullar injury, Parkinson disease, Shy-Drager syndrome), collagenosis, vasculitis, myopathy (e.g.
sclerodermatitis, amyloidosis, dermatomyositis), intoxication with heavy metals (e.g. Pb, As, Hg)
Concomitant medication:
Romania | |
IFE Human Pharmacology | |
Timisoara, Romania, Ro-300244 |
Study Director: | Hans-Jürgen Gruss, MD | Norgine |
Principal Investigator: | Rodica Cinca, MD | IFE Human Pharmacology |
Responsible Party: | Norgine Ltd ( Vice President Clinical Development ) |
Study ID Numbers: | PEG-01/2007(ELE) |
Study First Received: | March 24, 2009 |
Last Updated: | March 24, 2009 |
ClinicalTrials.gov Identifier: | NCT00868985 History of Changes |
Health Authority: | Romania: State Institute for Drug Control |
Signs and Symptoms Signs and Symptoms, Digestive Constipation |
Signs and Symptoms Signs and Symptoms, Digestive Constipation |